THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT
Live / Registered — Registered (as of 13 Jun 2023)
What this means for you
Registered since 13 Jun 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88165746
- Registration number
- 7080874
- Mark type
- Stylized text
- Filed
- 23 Oct 2018
- Published for opposition
- 26 Feb 2019
- Registered
- 13 Jun 2023
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the digestive system, the excretory system, the endocrine system, the integumentary system, the exocrine system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, and/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposes, namely, for non-addictive pain management; none of the foregoing items comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis and none of which are comprised of cannabidiol (CBD)
Owner
- Vivera Pharmaceuticals, Inc., Newport Beach, CA, US
- Vivera Pharmaceuticals, Inc., Newport Beach, CA, US
- Vivera Pharmaceuticals, Inc., Newport Beach, CA, US
Prosecution history
- 07 Mar 2024 — WITHDRAWAL OF ATTORNEY GRANTED
- 07 Mar 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 13 Jun 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Jun 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 May 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 May 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Mar 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Mar 2023 — ASSIGNED TO EXAMINER
- 13 Mar 2023 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 13 Mar 2023 — ASSIGNED TO EXAMINER
- 13 Mar 2023 — WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
- 13 Mar 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Jan 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jan 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jan 2023 — ASSIGNED TO LIE